The research objective of Alexander Revzin, Ph.D., is to improve the understanding of liver fibrosis and other diseases by developing new ways of culturing cells and analyzing cell function. Dr. Revzin's laboratory utilizes microfabrication, microfluidics and biosensors to create microphysiological systems (organs-on-chip).
- Liver fibrosis and injury
- Stem cell cultivation
- Biosensors for analysis of blood and other biological fluids
Significance to patient care
Research in Dr. Revzin's lab aims to develop novel therapies for liver fibrosis to improve patients' quality of life and treatment outcomes.
- Associate editor, Microsystems & Nanoengineering (Nature group journal) 2014-present
- Fellow, American Institute for Medical and Biological Engineering, 2015
- Program director, Nano-Biosensing, National Science Foundation, 2013-2014
- Chancellor's fellow, University of California, 2012